Upgrade to SI Premium - Free Trial

Telix Pharmaceuticals (TLX)

10.32 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/14/26 *Est.)

Latest Headlines

Telix Pharmaceuticals Ltd (TLX:AU) (TLX) PT Raised to AUD24.40 at JPMorgan July 22, 2026 6:48 AM - StreetInsider Telix publishes Phase 1 prostate cancer therapy study in Cancers journal July 21, 2026 5:00 PM - StreetInsider TLX591-Tx ProstACT SELECT Study Published in Cancers Journal July 21, 2026 5:00 PM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: Jun 30 July 21, 2026 7:06 AM - SEC Filing Telix Pharmaceuticals Limited (TLX) Reports Q2 results July 21, 2026 3:28 AM - StreetInsider Telix Pharmaceuticals posts $247M in Q2 revenue, raises R&D outlook July 20, 2026 7:41 PM - StreetInsider Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress July 20, 2026 7:31 PM - Globe NewsWire Telix doses first patient in Phase 3 kidney cancer drug trial July 20, 2026 5:00 PM - StreetInsider Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer July 20, 2026 5:00 PM - Globe NewsWire RBC Capital Downgrades Telix Pharmaceuticals Ltd (TLX:AU) (TLX) to Sector Perform July 17, 2026 2:30 AM - StreetInsider First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer July 15, 2026 4:20 PM - Globe NewsWire Citi Opens 30-Day upside catalyst watch on Telix Pharmaceuticals Ltd (TLX:AU) (TLX) July 14, 2026 4:11 PM - StreetInsider Telix Pharmaceuticals Ltd (TLX:AU) (TLX) PT Lowered to AUD31 at Citi July 10, 2026 10:21 AM - StreetInsider Telix Pharmaceuticals Ltd (TLX) PT Lowered to $22 at Citi July 7, 2026 12:44 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) July 7, 2026 7:03 AM - StreetInsider Form 6-K Telix Pharmaceuticals For: Jul 01 July 2, 2026 4:28 PM - SEC Filing Telix gets FDA alignment to expand prostate cancer trial to U.S. July 1, 2026 9:31 PM - StreetInsider FDA Alignment to Advance ProstACT Global Phase 3 Trial July 1, 2026 9:31 PM - Globe NewsWire Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions June 22, 2026 5:40 PM - StreetInsider Telix and United Imaging form theranostics collaboration June 2, 2026 7:01 AM - StreetInsider Telix and United Imaging Announce Strategic Theranostics Collaboration June 2, 2026 7:00 AM - Globe NewsWire Telix presents prostate cancer trial data showing acceptable safety June 1, 2026 5:00 PM - StreetInsider ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 June 1, 2026 5:00 PM - Globe NewsWire JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight June 1, 2026 12:55 AM - StreetInsider Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences May 27, 2026 7:00 AM - Globe NewsWire Form 6-K Telix Pharmaceuticals For: May 20 May 21, 2026 4:11 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: GILL DAVID N May 18, 2026 6:34 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: Jellison William R May 18, 2026 6:33 PM - SEC Filing Form 3 Telix Pharmaceuticals For: May 11 Filed by: Rivas Maria May 18, 2026 6:32 PM - SEC Filing Telix completes enrollment for first-line glioblastoma study May 18, 2026 5:00 PM - StreetInsider IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing May 18, 2026 5:00 PM - Globe NewsWire Telix partners with EDAP and Profound on prostate imaging tech May 15, 2026 6:31 AM - StreetInsider Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches May 15, 2026 6:30 AM - Globe NewsWire Form 4 Telix Pharmaceuticals For: Apr 28 Filed by: Behrenbruch Christian May 6, 2026 9:32 PM - SEC Filing Telix study shows cancer imaging drug may detect broader kidney tumors May 4, 2026 5:01 PM - StreetInsider New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC May 4, 2026 5:00 PM - Globe NewsWire TLX101-Px (Pixlumi®) MAA Accepted in Europe April 30, 2026 5:43 PM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX) April 30, 2026 6:53 AM - StreetInsider Telix presents dosimetry data for prostate cancer drug candidate April 29, 2026 5:01 PM - StreetInsider OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer April 29, 2026 5:00 PM - Globe NewsWire Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach April 27, 2026 7:27 PM - Globe NewsWire Full Article List